Holen Sie sich die Stockscreener-App
390.79
0.03%
-0.11
Vorhandelsmarkt:
391.92
1.13
+0.29%
Schlusskurs vom Vortag:
$390.90
Offen:
$386.94
24-Stunden-Volumen:
1.68M
Relative Volume:
1.18
Marktkapitalisierung:
$56.33B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-238.11
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+13.16%
1M Leistung:
+17.70%
6M Leistung:
+95.31%
1J Leistung:
+126.11%
1-Tages-Spanne:
$384.96
$394.86
1-Wochen-Bereich:
$348.26
$394.86
52-Wochen-Spanne:
$157.43
$394.86
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
390.79 | 56.33B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
665.30 | 245.99B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.56 | 155.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
165.32 | 46.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
267.86 | 44.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Has Natera (NTRA) Run Ahead Of Fair Value After Its Japan Signatera Approval? - simplywall.st
Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar - Yahoo Finance
Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval - Inside Precision Medicine
Form 144 Natera For: 23 September By Investing.com - Investing.com Canada
Form 144 Natera For: 23 September - Investing.com India
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Yahoo Finance
$8.2M stock sale planned at Natera (NASDAQ: NTRA) - Stock Titan
Natera, Inc.Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - marketscreener.com
Why Is Natera (NTRA) Stock Soaring Today - Yahoo Finance
A Look at Natera Inc (NTRA) After 5.5% Gain -- GF Value $219.69 vs Price $390.90 - GuruFocus
Behavioral Patterns of NTRA and Institutional Flows - Stock Traders Daily
Natera Inc stock reaches all-time high at 373.58 USD By Investing.com - Investing.com Nigeria
Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement - TradingKey
Natera gains as fresh Signatera lung cancer data and upbeat analyst sentiment support shares - Quiver Quantitative
NTRA Looks 68.7% Overvalued on GF Value™ - GuruFocus
Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Finviz
Natera’s Signatera Receives Japanese Approval as CDx for Muscle-Invasive Bladder Cancer - GenomeWeb
Natera Inc stock reaches all-time high at 373.58 USD - Investing.com
Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027 - TradingView
A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment. - Stock Titan
Enterprise value to EBITDA ratio of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA.CI - TradingView
Final Trade: Uber, Micron, Natera and Datadog - CNBC
How Lung Cancer Data Will Impact Natera Stock Investors - simplywall.st
Natera, Inc. (NTRA) Stock Analysis: Amidst Rapid Growth, What Lies Ahead for This Diagnostics Leader? - DirectorsTalk Interviews
Natera stock gains as new lung cancer study supports Signatera value - AD HOC NEWS
Natera (NTRA) Study Of 1,100 Patients Supports Signatera In Lung Cancer - simplywall.st
Why Natera (NTRA) Is Up 12.3% After Landmark Lung Cancer MRD Data At IASLC 2026 - Yahoo Finance
Natera (NTRA) Stock Fair Value Rises After Signatera And Guidance Drive Analyst Revisions - Yahoo Finance
Natera CEO Steven Chapman Sells 1,698 Shares for $545,000 - fool.com
Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM - Business Wire
Show Me The Money: Natera Delivers Over 120% Gain In Just About A Year - RTTNews
Natera co-founder Sheena sells $3.2m in shares - Investing.com
Natera (NASDAQ: NTRA) co-founder sells 9,150 shares under 10b5-1 plan - Stock Titan
Natera(NTRA.US) Director Sells US$3.22 Million in Common Stock - Moomoo
Natera Inc (NTRA) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
Natera Inc Stock (NTRA) Moved Up by 5.05% on Sep 17: Key Drivers Unveiled - TradingKey
Natera Stock Has Excellent Technical ‘DNA’ as NTRA Sets a New All-Time High - Barchart.com
Natera executive chairman Matthew Rabinowitz sells $34.8m in stock - Investing.com
Natera executive chairman Matthew Rabinowitz sells $34.8m in stock By Investing.com - Investing.com Nigeria
Natera (NASDAQ: NTRA) chair unloads stock in preset plan - Stock Titan
Natera at 2026 Global Healthcare Conference: growth broadens By Investing.com - Investing.com Australia
Natera at 2026 Global Healthcare Conference: growth broadens - Investing.com
Is Natera (NTRA) Fully Priced Or Still A Bargain On Conference Buzz? - simplywall.st
Trust tied to Natera (NASDAQ: NTRA) eyes new stock sale after multimillion-dollar trades - Stock Titan
Natera stock hits all-time high at 343.94 USD By Investing.com - Investing.com Australia
Natera stock hits all-time high at 343.94 USD - Investing.com India
Natera, Inc. (NTRA) Stock Analysis: A $47 Billion Market Cap Powerhouse with a Robust Growth Trajectory - DirectorsTalk Interviews
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy? - The Motley Fool
Understanding Momentum Shifts in (NTRA) - Stock Traders Daily
Did Earnings Beat Just Shift Natera (NTRA) Investment Narrative? - webull.com
Natera(NTRA.US) Officer Sells US$16.4 Million in Common Stock - Moomoo
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):